"
Team:Tufts/future
From 2014.igem.org
(Difference between revisions)
| Line 59: | Line 59: | ||
<a href = "https://2014.igem.org/Team:Tufts/survey"> Survey </a> <br> | <a href = "https://2014.igem.org/Team:Tufts/survey"> Survey </a> <br> | ||
| - | + | <!-- | |
<h4>Summary </h4> | <h4>Summary </h4> | ||
| Line 76: | Line 76: | ||
--- Intermission --- <br> | --- Intermission --- <br> | ||
7. Panel – Anna Kuchment, Dr. Robin Pierce, Dr. Andrew Camilli, Mark Mimee <br> | 7. Panel – Anna Kuchment, Dr. Robin Pierce, Dr. Andrew Camilli, Mark Mimee <br> | ||
| - | + | --> | |
<object width="100%" height="1500px" data="https://static.igem.org/mediawiki/2014/c/c5/Tufts_conference.pdf"> </object> | <object width="100%" height="1500px" data="https://static.igem.org/mediawiki/2014/c/c5/Tufts_conference.pdf"> </object> | ||
</div> | </div> | ||
</html> | </html> | ||
Revision as of 05:33, 17 October 2014
This October, Tufts Synthetic Biology hosted a conference, The Future of Phage and Synthetic Biology, which brought together experts from academia, industry, and regulation to discuss and present on emerging research concerning the applications of phage - specifically bacteriophage therapy.
Application Scenarios
Techno-Moral Scenarios
Survey
